TABLE 1

Characteristics of the study groups

Control subjectsLong-term type 1 diabetic subjectsNewly diagnosed type 1 diabetic subject
n201921
M/F (n)13/713/612/9
Age (years)31.2 ± 8.525.1 ± 8.829.9 ± 4
Time since diagnosis (years)N/A5 (7 months–30 years)0.24 (2 weeks–5 months)
HLA DR 04/X*3542.133.3
HLA DR 03/X302119.1
HLA DR 04/03526.323.8
HLA DR X/X3010.523.8
  • *

    * HLA DRB1 04/X includes 04/04 homozygotes; HLA DRB1 03/X includes 03/03 homozygotes. Data are means ± SD, median (range), and %, unless otherwise indicated.